Substance / Medication

Gentian violet

Overview

Active Ingredient
gentian violet
RxNorm CUI
4778

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Comparison of Recovery Rate of Otomycosis using One-Percent Gentian Violet and One-Percent Clotrimazole Topical Treatment.
Dhakal Srijana, Bagale Gyanendra, Nepal Ajit et al. · J Nepal Health Res Counc · 2024
PMID: 39572944RCT
Effect of intravaginal gentian violet for acute vaginal candidiasis treated with a single dose oral fluconazole: a randomised controlled trial.
Chayachinda Chenchit, Thamkhantho Manopchai, Ngamsakulrungroj Popchai et al. · J Obstet Gynaecol · 2022
PMID: 35253598RCT
Successful Treatment of Severe Tungiasis in Pigs Using a Topical Aerosol Containing Chlorfenvinphos, Dichlorphos and Gentian Violet.
Mutebi Francis, von Samson-Himmelstjerna Georg, Feldmeier Hermann et al. · PLoS Negl Trop Dis · 2016
PMID: 27727268RCTFull text (PMC)
Identification of gentian violet concentration that does not stain oral mucosa, possesses anti-candidal activity and is well tolerated.
Jurevic R J, Traboulsi R S, Mukherjee P K et al. · Eur J Clin Microbiol Infect Dis · 2011
PMID: 21210170RCTFull text (PMC)
Role of gentian violet paint in burn wound management: a prospective randomised control trial.
Choudhary K N, Soni P P, Sao D K et al. · J Indian Med Assoc · 2013
PMID: 24475556Observational
In vitro assessment of gentian violet anti- candida activity.
Gomes-de-Elvas A R, Palmeira-de-Oliveira A, Gaspar C et al. · Gynecol Obstet Invest · 2012
PMID: 22889741Observational
Comparison of methylene blue/gentian violet stain to Gram's stain for the rapid diagnosis of gonococcal urethritis in men.
Taylor Stephanie N, DiCarlo Richard P, Martin David H · Sex Transm Dis · 2011
PMID: 21992973Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Methylrosanilinium chloride (substance)
SNOMED CT
387239001
UMLS CUI
C0017440
RxNorm CUI
4778

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.